Increased activity of plasminogen activator inhibitor 1 (PAI-1) is associated with kidney fibrosis it can be seen in chronic allograft nephropathy, chronic glomerulonephritis, diabetic nephropathy, and hypertensive nephrosclerosis (28, 29). This evidence concerns the gene SERPINE1 and Crouzon syndrome-acanthosis nigricans syndrome.